Skip to main content

Neuroscience Startups

Updated November 2026

Companies in the neuroscience sector developing innovative solutions and technologies.

Explore 340 recently funded neuroscience companies with verified founder contact information and fundraising data.

Total Companies
340
Total Funding
$1.3B
Avg Funding
$53.4M
Global Reach
11
countries

Top Cities for Neuroscience

Tokyo
Boston
Cambridge
Santa Barbara
Risch
London

Recently Funded Companies

Export
Tokyo, Japan

LIFESCAPES develops Brain-Machine Interface technology to support rehabilitation for patients with severe paralysis following strokes.

$307K raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

$200.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Coherence develops healthcare tech linking cancer neuroscience with neurotechnology for new treatments.

$45.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Santa Barbara, United States

Cognixion is a neural interface startup creates AI-powered products for individuals with disabilities.

$900K raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Risch, Switzerland

NeuroGyn develops neurostimulation systems and minimally invasive neuromodulation procedures for treating pelvic and systemic disorders.

$4.8M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

London, United Kingdom

MintNeuro is a semiconductor company developing integrated circuits for neural devices and neurotechnology applications.

$5.0M raised
Oct 2026

Founder Contacts

41,000+ verified contacts

Manhattan, United States

Precision Neuroscience develops brain-computer interfaces for people with paralysis.

$250.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Pikérmi, Greece

Anacalypsis Therapeutics is a biotechnology company that develops medications and biomarkers for neurodegenerative diseases.

$344K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Utrecht, The Netherlands

UCANACT is a digital assistive technology paired with wearables or implants to give motor-disabled individuals control over digital devices.

$923K raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Framingham, United States

Alzheon is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.

$78.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of the central nervous system.

$4.2M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Charlottesville, United States

Navion Neurosciences is a pre-clinical stage biotechnology company that develops sodium channel therapeutics for neurological diseases.

$10.8M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

$50.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

$380.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Seattle, United States

BrainChild Bio develops chimeric antigen receptor T-cell therapies engineered to treat tumors of the central nervous system.

$116.0M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Worcester, United States

AiM Medical Robotics is a biotechnology company developing a robotic system for use in neurosurgical procedures.

$8.1M raised
Sep 2026

Founder Contacts

41,000+ verified contacts

Suisse, France

Bewelab is the first neuroscience-based digital intervention targeting cravings at the neural level.

$2.5M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Worcester, United States

Leal Therapeutics develops novel therapeutics for patients.

$30.0M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Champaign, United States

Archean Sciences builds AI-powered biological systems to decode the brain and accelerate discovery through autonomous experimentation.

$385K raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Helsinki, Finland

Aiforia’s mission is to provide global access to AI-powered image analysis for medical, healthcare professionals and beyond.

$23.1M raised
Aug 2026

Founder Contacts

41,000+ verified contacts

Newton, United States

Magnendo develops AI-powered endoscopy and robotics technologies for gastrointestinal disease detection, diagnosis, and clinical support.

$18.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Los Altos, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

$100.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Schweinfurt, Germany

SKILLCOURT provides a sensor-based diagnostic and training system for visual, cognitive, and motor skills.

$1.9M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Sharper Sense is a wearable patch that stimulates a neck nerve to improve hearing, vision, and touch.

$100K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Columbus, United States

NeuroLife technology is designed to support applications across rehabilitation, neuromuscular analytics and future neuro-enabled solutions.

$2.9M raised
Jun 2026

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 340 companies

About the Neuroscience Startup Ecosystem

The neuroscience sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Neuroscience

Neuroscience companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The neuroscience sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Neuroscience Funding Breakdown

Here is how funding is distributed among the 340 neuroscience companies tracked in the VCBacked database.

Average Funding
$53.4M
Total Funding Tracked
$1.3B
Countries Represented
11

Distribution by Funding Stage

Other25 companies

Top Cities for Neuroscience

1.Worcester
2 companies$38.1M
2.Tokyo
1 companies$307K
3.Boston
1 companies$200.0M
4.Cambridge
1 companies$45.0M
5.Santa Barbara
1 companies$900K

Related Industries

Companies in the neuroscience sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Neuroscience Startups?

Perfect for: B2B sales teams targeting neuroscience companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked